Clinical Trial: Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department

Brief Summary: It is estimated that epistaxis results in 4.5 million emergency department visits per year throughout the United States. Due to the adverse effects of standard treatment options for epistaxis, tranexamic acid (TXA) may be considered an attractive option. In previous studies, when used with nasal packing, TXA showed faster time to control of bleeding. The goal of this study is to determine the efficacy and safety of topical intranasal TXA applied via atomizer for patients with epistaxis who present to the emergency department.